Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 18:11:1-5.
doi: 10.2147/CCID.S130116. eCollection 2018.

Xanthelasma palpebrarum - a brief review

Pragya A Nair  1 , Rochit Singhal  1
Affiliations
Review

Xanthelasma palpebrarum - a brief review

Pragya A Nair et al. Clin Cosmet Investig Dermatol. .

Abstract

Xanthelasma palpebrarum is the most common cutaneous xanthoma, characterized by yellowish plaques over eyelids - most commonly, over the inner canthus of the upper lid. It is triggered by hyperlipidemia, thyroid dysfunction, and diabetes mellitus. Xanthelasma results from perivascular infiltration of mono- and multinucleated foam cells within lipid-laden cytoplasmic vacuoles in the superficial reticular dermis. Different modalities of treatment, such as simple surgical excision, cryotherapy, chemical peeling with trichloroacetic acid, radiofrequency, and laser, are used in the treatment of xanthelasma palpebrarum. A brief review of current treatment strategies is presented here.

Keywords: cryotherapy; hyperlipidemia; laser; xanthelasma palpebrarum; xanthoma.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Algorithm for management of a patient with xanthelasma palpebrarum. Abbreviations: IHD, ischemic heart disease; LDL, low density lipoprotein.
See this image and copyright information in PMC

References

    1. Segal P, Insull W, Jr, Chambless LE, et al. The association of dyslipoproteinemia with corneal arcus and xanthelasma. The lipid research clinics program prevalence study. Circulation. 1986;73(1 Pt 2):I108–I118. - PubMed
    1. Jonsson A, Sigfiisson N. Significance of xanthelasma palpebrarum in the normal population. Lancet. 1976;76:372. - PubMed
    1. Gangopadhyay DN, Dey SK, Chandra M, Pal D, Chaudhary S. Serum lipid profile in xanthelasma. Indian J Dermatol. 1998;43:53–56.
    1. Raulin C, Schoenermark MP, Werner S, Greve B. Xanthelasma palpebrarum: treatment with the ultrapulsed CO2 laser. Lasers Surg Med. 1999;24(2):122–127. - PubMed
    1. Rohrich RJ, Janis JE, Pownell PH. Xanthelasma palpebrarum: a review and current management principles. Plast Reconstr Surg. 2002;110(5):1310–1313. - PubMed

LinkOut - more resources